Breast Implants Market Global Analysis

Text-only Preview

Global Market Study on Breast Implants: Silicone
Breast Impacts Segment Likely to be the Dominant
Segment between 2016 and 2024
Global Breast Implants Market 2016-2024
P e r s i s t e n c e M a r k e t R e s e a r c h
Report Media Releases
Global Breast Implants Market to Reach US$ 1,482.1 Mn by
2024 End; Rising Popularity of Silicone Breast Implants
Expected to Fuel Revenue Growth
The global breast implants market is anticipated to register a CAGR of 4.1% during the
forecast period 2016–2024. In a new report titled “Breast Implants Market: Global Industry
Analysis and Forecast, 20162024”, Persistence Market Research analyzes the factors and trends
impacting the growth of the global breast implants market during the aforementioned period.
Greater emphasis on physical appearance and rise in global disposable per capita income of
women are the key factors expected to boost the growth of the global breast implants market
during the forecast period. Other prominent growth drivers are a growing prevalence of breast
cancer and the availability of an expanded product line with premium pricing leading to greater
sales. However, factors such as increased risk of developing serious complications including
deflation, capsular contracture, infection, and breast and nipple sensitivity; and high costs of the
implant procedure are expected to restrain the growth of the global breast implants market over
the forecast period.
Download Sample Report @ http://www.persistencemarketresearch.com/samples/10972
The global breast implants market has been segmented on the basis of Product Type (Silicone
Breast Implants, Saline Breast Implants); Shape (Round Breast Implants, Anatomical Breast
Implants); Application (Cosmetic Surgery, Reconstructive Surgery); End User (Hospitals,
Cosmetology Clinics); and Region (North America, Latin America, Europe, Asia Pacific, and
MEA). The Silicone Breast Implants product type segment is expected to account for 90.4%
revenue share of the global breast implants market by 2016 end. The Round Breast Implants
shape segment is anticipated to reach a market valuation of US$ 1,225.6 Mn by the end of 2024,
registering a CAGR of 4.2% over the forecast period. The Cosmetic Surgery application segment
is estimated to hold 79.4% revenue share of the global breast implants market by the end of
2016. The Hospitals end user segment is projected to account for 64.0% revenue share of the
global breast implants market by the end of 2016. The Hospitals segment is expected to emerge
Global Breast Implants Market 2016-2024
P e r s i s t e n c e M a r k e t R e s e a r c h
as the most attractive end user segment in the global breast implants market as women
increasingly prefer being treated by a plastic surgeon in hospitals rather than cosmetic clinics.
Among regions, the North America breast implants market is estimated to represent absolute $
opportunity of US$ 20.31 Mn in 2023 over 2022. The North America market is anticipated to
register a CAGR of 4.0% during the forecast period. The Asia Pacific market is slated to witness
high market growth in terms of revenue owing to a rapidly ageing baby boomer population and
rising disposable income. However, the breast implants market in the MEA region is likely to
witness restricted growth owing to a lack of awareness and other restrictions prevalent in the
region. The Latin America breast implants market is projected to register a CAGR of 4.3% during
the forecast period. Growing medical tourism in Latin American countries such as Brazil and
Mexico is driving the growth of the global breast implants market.
Download Report Table of Content, Figures, and Tables @
http://www.persistencemarketresearch.com/market-research/breast-implant-
market/toc
The report on the global breast implants market profiles some of the leading market players
dominating the global breast implants market. The companies featured in the report are Allergan
Plc., Mentor Worldwide LLC., GC Aesthetics Plc., Sientra Inc., Groupe Sebbin SAS, Polytech
Health & Aesthetics GmbH, Establishment Labs S.A., HansBiomed Co. Ltd., and CEREPLAS.
These companies are primarily focused on enhancing their product portfolio through strategic
investments in technology research and development initiatives and are focusing on the
introduction of innovative and cost-effective treatment procedures in order to gain higher market
share and to strengthen their respective positions in the global breast implants market.